$5.87 Billion is the total value of Hillhouse Capital Management's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 118.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $1,207,511,000 | +323.3% | 6,508,438 | +318.7% | 20.58% | +308.9% |
| FGEN | Buy | FIBROGEN INC | $168,156,000 | +39.9% | 2,686,196 | +3.2% | 2.87% | +35.1% |
| SNAP | Buy | SNAP INCcl a | $143,853,000 | +49.4% | 10,989,529 | +81.1% | 2.45% | +44.3% |
| BIDU | New | BAIDU INCspon adr rep a | $108,094,000 | – | 444,831 | +100.0% | 1.84% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $99,529,000 | – | 5,736,527 | +100.0% | 1.70% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $95,222,000 | +201.5% | 4,328,289 | +203.0% | 1.62% | +191.4% |
| YY | Buy | YY INC | $94,701,000 | +67.0% | 942,575 | +74.9% | 1.61% | +61.4% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $90,837,000 | -27.6% | 1,430,949 | +4.6% | 1.55% | -30.1% |
| KANG | Buy | IKANG HEALTHCARE GROUP INCsponsored adr | $59,801,000 | +7.7% | 2,922,834 | +5.0% | 1.02% | +4.0% |
| LN | Buy | LINE CORPsponsored adr | $49,603,000 | +20.5% | 1,207,763 | +14.5% | 0.84% | +16.4% |
| NOAH | New | NOAH HLDGS LTDspon ads cl a | $46,515,000 | – | 891,942 | +100.0% | 0.79% | – |
| MYOK | Buy | MYOKARDIA INC | $42,617,000 | +15.2% | 858,340 | +13.2% | 0.73% | +11.2% |
| SOHU | New | SOHU COM LTDsponsored ads | $28,472,000 | – | 802,034 | +100.0% | 0.48% | – |
| FB | New | FACEBOOK INCcl a | $23,175,000 | – | 119,261 | +100.0% | 0.40% | – |
| UXIN | New | UXIN LTDads | $22,600,000 | – | 2,500,000 | +100.0% | 0.38% | – |
| LOXO | New | LOXO ONCOLOGY INC | $14,104,000 | – | 81,300 | +100.0% | 0.24% | – |
| NEW | New | PUXIN LTDads | $13,454,000 | – | 628,673 | +100.0% | 0.23% | – |
| GSAHU | New | GS ACQUISITION HLDGS CORPunit 06/12/2023 | $10,200,000 | – | 1,000,000 | +100.0% | 0.17% | – |
| INCY | New | INCYTE CORP | $9,583,000 | – | 143,030 | +100.0% | 0.16% | – |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $9,390,000 | +43.1% | 767,128 | +80.5% | 0.16% | +37.9% |
| NTGN | New | NEON THERAPEUTICS INC | $8,969,000 | – | 711,809 | +100.0% | 0.15% | – |
| CJJD | New | CHINA JO-JO DRUGSTORES INC | $6,970,000 | – | 4,840,000 | +100.0% | 0.12% | – |
| NKTR | Buy | NEKTAR THERAPEUTICS | $5,248,000 | -4.8% | 107,471 | +107.2% | 0.09% | -8.2% |
| EIDX | New | EIDOS THERAPEUTICS INC | $4,577,000 | – | 225,000 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.